Fidelity Small Cap Growth Fund Q4 2025 Commentary

Fidelity Investments930 FollowersFollow5ShareSavePlay(6min)CommentsSummaryThe fund's Retail Class shares gained 3.16% for the three months, outperforming the 1.22% advance of the Russell 2000® Growth Index.The fund's biggest individual relative contributor was an overweight in Cogent Biosciences, which gained 147% the past quarter.As 2026 begins, the global and U.S. business cycles remain constructive, with monetary and fiscal easing in the U.S. likely to continue.While we are cognizant of macroeconomic and geopolitical conditions, we continue to build the portfolio from the bottom up, company by company. Donny DBM/iStock via Getty Images Performance Review The fund's Retail Class shares gained 3.16% for the three months, outperforming the 1.22% advance of the Russell 2000® Growth Index. We'll note that longer-term performance comparisons largely favor the fund. DuringThis article was written byFidelity Investments930 FollowersFollowFidelity’s mission is to strengthen the financial well-being of our customers and deliver better outcomes for the clients and businesses it serves. With assets under administration of $12.6 trillion, including discretionary assets of $4.9 trillion as of December 31, 2023, Fidelity focuses on meeting the unique needs of a broad and growing customer base. Privately held for 77 years, Fidelity employs more than 74,000 associates with its headquarters in Boston and a global presence spanning nine countries across North America, Europe, Asia and Australia. Note: This account is not managed or monitored by Fidelity, and any messages sent via Seeking Alpha will not receive a response. For inquiries or communication, please use Fidelity's official channels.